Loading clinical trials...

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1/2NCT01733589

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Resistance of hypoxic tumor cells to radiation is a significant reason of failure in the local control of tumors, especially the squamous cell carcinomas. Preclinical models have shown that Endostar m...

Lead sponsor: Zhejiang Cancer Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Not Yet Recruiting

Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

NCT06591910 · Unresectable Stage III Non-small-cell Lung Cancer

UNKNOWNPhase 2

A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer

NCT04181372 · Stage III Non-small-cell Lung Cancer

UNKNOWNPhase 2

Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer

NCT01576796 · Stage III Non-small-cell Lung Cancer

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 14, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1/PHASE2

Enrollment73

Start dateNov 2012

Last updatedJul 14, 2017

Condition

Stage III Non-small-Cell Lung Cancer

Locations shown

Zhejiang Cancer Hospital

Hangzhou, Zhejiang

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 14, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions